Literature DB >> 7527756

New uses for allopurinol.

R O Day1, D J Birkett, M Hicks, J O Miners, G G Graham, P M Brooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7527756     DOI： 10.2165/00003495-199448030-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  25 in total

1.  Influence of allopurinol on cardiac complications in open heart operations.

Authors:  M A Rashid; G William-Olsson
Journal:  Ann Thorac Surg       Date:  1991-07       Impact factor: 4.330

2.  Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.

Authors:  R H Gallerano; J J Marr; R R Sosa
Journal:  Am J Trop Med Hyg       Date:  1990-08       Impact factor: 2.345

3.  Gout and hyperuricaemia.

Authors:  R I Faragher; D J Caelli
Journal:  Aust Fam Physician       Date:  1987-06

Review 4.  The quest for a cure.

Authors:  G B Elion
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

5.  Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

Authors:  B Ettinger; A Tang; J T Citron; B Livermore; T Williams
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

6.  The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration.

Authors:  A S Salim
Journal:  Intern Med       Date:  1993-05       Impact factor: 1.271

7.  Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.

Authors:  K R Hande; R M Noone; W J Stone
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

Review 8.  Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis.

Authors:  J J Marr
Journal:  J Lab Clin Med       Date:  1991-08

9.  Allopurinol in the treatment of American cutaneous leishmaniasis.

Authors:  S Martinez; J J Marr
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

10.  Allopurinol as add-on therapy in refractory epilepsy: a double-blind placebo-controlled randomized study.

Authors:  P G Zagnoni; A Bianchi; P Zolo; R Canger; C Cornaggia; P D'Alessandro; P DeMarco; F Pisani; M Gianelli; L Verzé
Journal:  Epilepsia       Date:  1994 Jan-Feb       Impact factor: 5.864
View more
  4 in total

1.  Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.

Authors:  K Turnheim; P Krivanek; R Oberbauer
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

2.  Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.

Authors:  I Walter-Sack; J X de Vries; C Kutschker; A Ittensohn; A Voss
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors.

Authors:  A P Schmidt; A E Böhmer; C Antunes; C Schallenberger; L O Porciúncula; E Elisabetsky; D R Lara; D O Souza
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

Review 4.  Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.

Authors:  Richard O Day; Garry G Graham; Mark Hicks; Andrew J McLachlan; Sophie L Stocker; Kenneth M Williams
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.